Grancalcin Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Grancalcin monoclonal antibodies for research focused on understanding this important calcium-binding protein. Grancalcin Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Grancalcin plays a critical role in cellular processes such as calcium signaling, apoptosis, and the regulation of immune responses. Its involvement in multiple pathways highlights its significance in both normal physiology and disease states, making Grancalcin an essential target for scientific investigation. Research has shown that Grancalcin expression levels can vary significantly in different tissue types and under various physiological conditions. Understanding Grancalcin function can provide insights into various pathological conditions, including cancer and neurodegenerative diseases. Advanced research techniques have revealed new aspects of Grancalcin's molecular interactions and cellular distribution patterns. Ongoing studies continue to uncover novel functions and regulatory mechanisms of Grancalcin in cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of Grancalcin's role in human health and disease.